NCT02554409View on ClinicalTrials.gov

Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

October 13, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
PregnancyInfluenza
Interventions
BIOLOGICAL

Quadrivalent Intradermal Influenza Vaccine (QIV)

No Intervention as part of this protocol

Trial Locations (5)

19104

Philadelphia

Unknown

San Diego

Miami

Albany

Nashville

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02554409 - Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry | Biotech Hunter | Biotech Hunter